Inventiva SA Schedule 13D activist filings
Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.
NASDAQ
IVA
Inventiva SANew Enterprise Associates and affiliated entities have reduced their beneficial ownership in Inventiva S.A. to below 5% due to an increase in the issuer's outstanding shares.
NASDAQ
IVA
Inventiva SASamsara BioCapital and Opportunity Funds, along with Dr. Srinivas Akkaraju, increased their beneficial ownership in Inventiva S.A. to 7.4% following a $20 million American Depositary Share purchase.
NASDAQ
IVA
Inventiva SASCHEDULE 13D/A: Inventiva S.A. Investor Group Dips Below 5% Stake
An investor group led by Biotechnology Value Fund (BVF) has reported a decrease in its beneficial ownership of Inventiva S.A. to below 5%, primarily due to an increase in the issuer's outstanding shares.
NASDAQ
IVA
Inventiva SASamsara BioCapital and its affiliates have acquired a 5.9% beneficial ownership in Inventiva S.A. through a multi-tranche private placement, with Dr. Srinivas Akkaraju joining the board.
NASDAQ
IVA
Inventiva SASCHEDULE 13D/A: Biotechnology Value Fund Affiliates Increase Stake in Inventiva S.A. Following €115.6 Million Capital Raise
Biotechnology Value Fund and its affiliates have significantly increased their beneficial ownership in Inventiva S.A. to 6.1% following the consummation of a multi-tranche capital raise totaling €115.6 million.
NASDAQ
IVA
Inventiva SASCHEDULE 13D/A: New Enterprise Associates Boosts Inventiva S.A. Stake to 6.0% Following Strategic Financing
New Enterprise Associates and its affiliated investment funds have increased their beneficial ownership in Inventiva S.A. to 6.0% through a recent financing round involving the purchase of pre-funded warrants and contingent warrants.